"@codagenix intranasal &quot;COVI-VAC&quot; seemed quite promising. But no news since last announcement in september? Their platform could be a game changer for various diseases. What happens? https://t.co/cfQx5v3jBd"

COVI-VAC (CDX-CoV) - Codagenix, Serum Institute of India

Jan 6, 2022